Syngenta Group has appointed Hengde Qin as chief executive officer, effective August 1, 2026, following what the company described as a “thorough nomination and succession process.”
Qin, currently chief operating officer and head of seeds, will succeed Jeff Rowe, who will remain in the role until the transition before returning to the United States from Syngenta Group’s global headquarters in Basel after nearly a decade with the company.
Chairman Fanrong Li said Qin’s “unique combination of operational, financial and commercial experience” made him the right choice to lead Syngenta into its next phase of development.
Execution credentials align with capital markets focus
The appointment marks a transition from within, rather than a strategic reset, suggesting the company remains broadly confident in its existing direction.
Although Syngenta has not explicitly linked the appointment to its long-anticipated Hong Kong IPO, Qin’s profile aligns closely with what investors typically expect from leadership in the run-up to a public listing.
A long-standing member of the executive team, Qin has held senior roles spanning finance, operations and human resources, including stints as chief financial officer and president of Syngenta Group China. In the latter role, he oversaw a period of strong growth and profitability, helping establish China as one of the company’s top-performing divisions.
He also brings prior experience as CEO of listed companies in mainland China and Hong Kong. This can be viewed as an increasingly relevant credential as Syngenta explores capital markets in the region.
Taken together, the appointment suggests a focus on financial discipline, operational delivery and organisational integration; all key priorities for companies preparing for IPO.
Innovation and sustainability central to strategy
Qin also underlined the company’s longer-term strategic direction, placing sustainability and resilience at the centre of its mission.
“Agriculture stands at the center of the world’s most important challenges – from feeding a growing population to improving sustainability and resilience across food systems,” he said, adding that Syngenta is “well positioned” to lead that transformation.
That vision aligns with the company’s growing focus on next-generation technologies. As outlined in AgNavigator’s recent interview with global technology scout Dave Hughes, Syngenta is increasingly betting on innovation across areas such as digital agronomy, biological crop protection agents, biofertilisers and biostimulants to reduce environmental impact while maintaining yields.
These priorities reinforce a broader strategy to shift beyond traditional crop protection towards integrated, tech-enabled farming solutions.
China ties reinforce Hong Kong narrative
Qin’s appointment also underscores Syngenta’s positioning as a China-owned global agribusiness, following its acquisition by Sinochem.
His leadership of the China business, combined with his experience in Asian capital markets, strengthens alignment with both Chinese backers and potential investors in Hong Kong.
While the company maintains its global headquarters in Basel, Switzerland, the move reflects a balancing act between international operations and Chinese ownership, particularly as geopolitical scrutiny of agricultural inputs intensifies.
Strategic focus as listing timeline approaches
Syngenta’s potential Hong Kong IPO – expected to be one of the largest in the agribusiness sector – remains a key strategic priority, even as timing has shifted amid market conditions.
Against that backdrop, Qin’s appointment points to a leadership model geared less towards transformation and more towards execution and investor readiness.
